BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Buti S, Bersanelli M, Massari F, De Giorgi U, Caffo O, Aurilio G, Basso U, Carteni G, Caserta C, Galli L, Boccardo F, Procopio G, Facchini G, Fornarini G, Berruti A, Fea E, Naglieri E, Petrelli F, Iacovelli R, Porta C, Mosca A. First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series. World J Clin Oncol 2021; 12(11): 1037-1046 [PMID: 34909398 DOI: 10.5306/wjco.v12.i11.1037]
URL: https://www.wjgnet.com/2218-4333/full/v12/i11/1037.htm
Number Citing Articles
1
Davide Bimbatti, Francesco Pierantoni, Eleonora Lai, Melissa Ballestrin, Nicolò Cavasin, Elisa Erbetta, Chiara De Toni, Umberto Basso, Marco Maruzzo. Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre ExperienceCancers 2023; 15(17): 4353 doi: 10.3390/cancers15174353
2
Catalin Baston, Andreea Ioana Parosanu, Ioana-Miruna Stanciu, Cornelia Nitipir. Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell CarcinomaBiomedicines 2024; 12(5): 1111 doi: 10.3390/biomedicines12051111
3
Nathaniel R. Wilson, Yusuf Acikgoz, Elshad Hasanov. Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment optionsInternational Journal of Cancer 2024; 154(6): 947 doi: 10.1002/ijc.34756